BIMASTAT ORAL SUSPENSION

국가: 아일랜드

언어: 영어

출처: HPRA (Health Products Regulatory Authority)

유효 성분:

NEOMYCIN SULFATE, SULFADIAZINE

제공처:

Cross Vetpharm Group Limited

ATC 코드:

QJ01RA02

INN (국제 이름):

NEOMYCIN SULFATE, SULFADIAZINE

복용량:

Unknown

약제 형태:

Oral Suspension

처방전 유형:

POM

치료 그룹:

Bovine

치료 영역:

Sulfonamides, combinations with other antibacterials excl. trimethoprim

치료 징후:

Antibacterial

승인 상태:

Authorised

승인 날짜:

1988-10-01

제품 특성 요약

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Bimastat Oral Suspension
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Oral suspension
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pre-ruminant calves.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of diarrhoea in pre-ruminant calves associated with infections caused by organisms known to be, or
suspected of being, susceptible to the combination of sulfadiazine and neomycin.
4.3 CONTRAINDICATIONS
Do not use in animals with known hypersensitivity to the active ingredients.
Do not exceed the recommended dosage or the period of treatment.
Do not use local anaesthetics of the procaine group during treatment as they are antagonistic to the sulphonamide
component.
Do not use in calves with functional rumens.
Do not use in lactating cows.
Do not use in foals and horses.
ACTIVE SUBSTANCE
Sulfadiazine
150.0 mg/ml
Neomycin (as neomycin sulphate) 25.0 mg/ml
EXCIPIENTS
Methyl parahydroxybenzoate
2.0 mg/ml
Propyl parahydroxybenzoate
0.2 mg/ml
Carmoisine E122
0.05 mg/ml
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 13/01/2016_
_CRN 7022820_
_page number: 1_
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Concurrent intravenous fluid therapy should be considered in dehydrated calves. Parenteral antibiotic treatment should
be considered if a clinical response is not seen after 48 hours treatment.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTION(S) FOR USE IN ANIMALS
Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy
should be based on local (regional, farm